The hematuria treatment market is projected to reach US$ 1,103.61 million by 2028 from US$ 932.89 million in 2021; it is expected to grow at a CAGR of 2.4% from 2021 to 2028.
Hematuria is a medical condition indicated by the presence of blood in the urine; under normal circumstances, urine does not contain RBCs. This can result in serious issue that may also cause kidney stones, urinary tract infection, and other inherited diseases. Factors such as the high prevalence of hematuria-associated indications, and increasing awareness about treatment options and improving healthcare expenditure are driving the market. However, the undiagnosed cases of associated indications that hamper the effectiveness of the treatment hinder the hematuria treatment market growth. Further, increasing scope for related treatments is expected to offer significant growth opportunities to the Hematuria Treatment market players to expand their customer base, especially in developing countries.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Hematuria Treatment Market: Strategic Insights
Market Size Value in US$ 932.89 million in 2021 Market Size Value by US$ 1,103.61 million by 2028 Growth rate CAGR of 2.4% from 2021 to 2028 Forecast Period 2021-2028 Base Year 2021
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Hematuria Treatment Market: Strategic Insights
| Market Size Value in | US$ 932.89 million in 2021 |
| Market Size Value by | US$ 1,103.61 million by 2028 |
| Growth rate | CAGR of 2.4% from 2021 to 2028 |
| Forecast Period | 2021-2028 |
| Base Year | 2021 |
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Europe witnessed exponential growth in the number of COVID-19 cases in 2020. Spain, Germany, France, Italy, and the UK are the most affected countries in the region. Proteinuria and hematuria are reported to have a greater prevalence among COVID-19 patients than that in AKI patients. Retrospective studies in China have reported that proteinuria and hematuria are observed in COVID-19 patients, and the conditions also associated with higher mortality. According to the COVID-19 database of the European Kidney Association (ERACODA), established in March 2020, ~25% of kidney transplant patients are diagnosed with SARS-CoV-2. Therefore, the COVID-positive patients are more likely to receive treatments against kidney diseases as well.
Lucrative Regions for Hematuria Treatment Market
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Market Insights
High Prevalence of Hematuria-Associated Indications Fuels Hematuria Treatment Market Growth
Chronic kidney disease (CKD) is a common and life-threatening condition that affects a larger population worldwide. There are various types of CKDs, such as kidney stones, glomerulonephritis, polycystic kidney disease, and urinary tract infections. CKD is one of the key causes behind the prevalence of hematuria. For instance, according to a study published in the National Center for Biotechnology Information in May 2019, urinary tract infections (UTIs) are generally observed as outpatient infections in the US, mostly occurring among women of the age group between 14 and 24 years. In addition, the prevalence of UTI among women over 65 years of age is about 20% compared to the overall population, which is about 11%. Currently, the global hematuria treatment market is gaining significantly from the increasing prevalence of associated indications. In North America, the U.S. is the largest market for the hematuria treatment market. The growth of this market is primarily driven by the increasing prevalence of chronic kidney disorders (CKD) and growing number of product launches by key players. For instance, in 2016, the Centers for Disease Control and Prevention (CDC) stated that an estimated 0.7 million people were treated for end-stage renal disease (ESRD) in the U.S. The prevalence of ESRD more than doubled between 1990 and 2016. Moreover, the increase in incidence of hematuria among adults, surge in awareness, extensive research & development activities, are also expected to drive the prevalence of hematuria treatments, which will eventually offer a lucrative opportunity for the growth of the market. Increasing geriatric population is also one of the major drivers for this market as aging is the prominent risk factor responsible for growing incidences of renal diseases. For instance, according to a study published by the Population Reference Bureau in 2020, the population age 65 years in the U.S. is expected to double by 2060.
Treatment-Based Insights
The hematuria treatment market, based on treatment, is segmented into drugs, therapies, and others. As hematuria is associated with various indications such as the UTI, kidney stone, blood cancer, bladder stones, and prostate cancer, the drugs used for these indications can also be used for its treatment. Alfuzosin, ciprofloxacin, doxazosin, ibuprofen, and tamsulosin are among the commonly used drugs for the hematuria treatment. This is a preferred treatment type as the drugs can be administered at home and in healthcare settings.
Hematuria Treatment Market, by Treatment – 2020 and 2028
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Indication-Based Insights
The hematuria treatment market, based on indication, is segmented into kidney stones, urinary tract infections (UTI), urethritis, blood cancer, bladder stones, prostate cancer, cystitis, trauma, vigorous exercise, polycystic kidney disease, endometriosis, and menstruation. In 2021, the urinary tract infections segment is likely to hold the largest share of the market. Moreover, the hematuria treatment market for urethritis segment is also expected to register the fastest CAGR of 3.1% during 2021 to 2028.
Type-Based Insights
The hematuria treatment market, based on type, has been segmented into macroscopic hematuria, microscopic hematuria, idiopathic hematuria, and jogger’s hematuria. The macroscopic hematuria segment is likely to hold the largest share of the market in 2021. However, the microscopic hematuria segment is anticipated to register the highest CAGR in the market during the forecast period.
End User-Based Insights
The hematuria treatment market, based on end user, is segmented into hospitals, clinics, ambulatory surgical centers (ASCs), and others. In 2021, the hospitals segment is expected to hold the largest share of the market. Further, the clinics segment is also expected to witness growth in its demand at the fastest CAGR of 6.9% during 2021 to 2028.
Companies operating in the hematuria treatment market adopt the treatment innovations strategy to meet the evolving customer demands across the world, which also permits them to maintain their brand name in the global market.
Hematuria Treatment Market – by Treatment
- Drugs
- Therapies
- Others
Hematuria Treatment Market – by Indication
- Urinary Tract Infections
- Kidney Stones
- Urethritis
- Blood Cancer
- Bladder Stones
- Prostate Cancer
- Cystitis, Trauma
- Vigorous Exercise
- Polycystic Kidney Disease
- Endometriosis
- Menstruation
Hematuria Treatment Market – by Type
- Macroscopic Hematuria
- Microscopic Hematuria
- Idiopathic Hematuria
- Jogger’s Hematuria
Hematuria Treatment Market – by End User
- Hospitals
- Clinics
- ASC’s
- Others
Hematuria Treatment Market– by Geography
North America
- US
- Canada
- Mexico
Europe
- France
- Germany
- Italy
- UK
- Spain
- Rest of Europe
Asia Pacific (APAC)
- China
- India
- South Korea
- Japan
- Australia
- Rest of APAC
Middle East and Africa (MEA)
- South Africa
- Saudi Arabia
- UAE
- Rest of MEA
South and Central America (SCAM)
- Brazil
- Argentina
- Rest of SCAM
Company Profiles
- AstraZeneca
- Bristol-Myers Squibb Company
- F. HOFFMANN-LA ROCHE LTD.
- GlaxoSmithKline plc.
- Janssen Pharmaceuticals
- Merck & Co., Inc.
- Novartis AG
- Pfizer Inc.
- Sun Pharmaceutical Industries Ltd
- Boehringer Ingelheim International GmbH
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Treatment, Indication, Type, End User and Geography
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States
Frequently Asked Questions
Hematuria is the presence of blood in the urine. Gross or visible hematuria occurs when the urine is red or pink, indicating the presence of blood in the urine. Blood can sometimes be found in the urine but is difficult to see; this is known as microscopic hematuria since it can only be seen under a microscope. The need for hematuria treatment has increased as the incidence of chronic renal disease and urinary tract infections has increased. Many tests, such as screening for sugar (diabetes), germs (infection), and blood, are performed on a regular basis. Blood can be detected with a chemical strip (also known as a dipstick) or under a microscope.
Key factors that are driving the growth of this market are high prevalence of hematuria-associated indications and increasing awareness about treatment options and improving healthcare expenditure are expected to boost the market growth for the hematuria treatments over the years.
The CAGR value of the hematuria treatments market during the forecasted period of 2021-2028 is 2.4%.
The drugs segment held the largest share of the market in the global hematuria treatments market and held the largest market share of 56.99% in 2020.
The urinary tract infections segment dominated the global hematuria treatments market and accounted for the largest market share of 17.31% in 2020.
The macroscopic hematuria segment dominated the global hematuria treatments market and held the largest market share of 48.04% in 2020.
The hospitals segment dominated the global hematuria treatments market and held the largest market share of 36.52% in 2020.
The hematuria treatments market majorly consists of the players such AstraZeneca, Bristol-Myers Squibb Company, F. HOFFMANN-LA ROCHE LTD., GlaxoSmithKline plc., Janssen Pharmaceuticals, Merck & Co., Inc., Novartis AG, Pfizer Inc., Sun Pharmaceutical Industries Ltd, Boehringer Ingelheim International GmbH among others.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Hematuria Treatment Market – By Treatment
1.3.2 Global Hematuria Treatment Market – By Indication
1.3.3 Global Hematuria Treatment Market – By Type
1.3.4 Global Hematuria Treatment Market – By End User
1.3.5 Global Hematuria Treatment Market – By Geography
2. Global Hematuria Treatment Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Hematuria Treatment Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America – PEST Analysis
4.2.2 Europe– PEST Analysis
4.2.3 Asia Pacific – PEST Analysis
4.2.4 Middle East and Africa – PEST Analysis
4.2.5 South and Central America (SCAM) – PEST Analysis
4.3 Experts Opinion
5. Hematuria Treatment Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 High Prevalence of Hematuria-Associated Indications
5.1.2 Increasing Awareness About Treatment Options and Improving Healthcare Expenditure
5.2 Market Restraints
5.2.1 Undiagnosed Cases of Associated Indications
5.3 Market Opportunities
5.3.1 Increasing Opportunities for Related Treatments
5.4 Future Trends
5.4.1 Rise in Preference for Advanced Therapies
5.5 Impact Analysis
6. Hematuria Treatment Market – Global Analysis
6.1 Global Hematuria Treatment Market Revenue Forecast and Analysis
6.2 Global Hematuria Treatment Market, By Geography - Forecast and Analysis
6.3 Market Positioning of Key Players
7. Hematuria Treatment Market Revenue and Forecast To 2028 – By Treatment
7.1 Overview
7.2 Global Hematuria Treatment Market Share by Treatment 2021 & 2028 (%)
7.3 Drugs
7.3.1 Overview
7.3.2 Drugs: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
7.4 Therapies
7.4.1 Overview
7.4.2 Therapies: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
7.5 Others
7.5.1 Overview
7.5.2 Others: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8. Hematuria Treatment Market Revenue and Forecast To 2028 – By Indication
8.1 Overview
8.2 Global Hematuria Treatment Market Share by Indication 2021 & 2028 (%)
8.3 Kidney Stones
8.3.1 Overview
8.3.2 Kidney Stones: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8.4 Urinary Tract Infections (UTI)
8.4.1 Overview
8.4.2 Urinary Tract Infections : Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8.5 Urethritis
8.5.1 Overview
8.5.2 Urethritis: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8.6 Blood Cancer
8.6.1 Overview
8.6.2 Blood Cancer: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8.7 Bladder Stones
8.7.1 Overview
8.7.2 Bladder Stones: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8.8 Prostate Cancer
8.8.1 Overview
8.8.2 Prostate Cancer: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8.9 Cystitis
8.9.1 Overview
8.9.2 Cystitis: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8.10 Trauma
8.10.1 Overview
8.10.2 Trauma: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8.11 Vigorous Exercise
8.11.1 Overview
8.11.2 Vigorous Exercise: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8.12 Polycystic Kidney Disease
8.12.1 Overview
8.12.2 Polycystic Kidney Disease: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8.13 Endometriosis
8.13.1 Overview
8.13.2 Endometriosis: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8.14 Menstruation
8.14.1 Overview
8.14.2 Menstruation: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
9. Hematuria Treatment Market Revenue and Forecast To 2028 – By Type
9.1 Overview
9.2 Global Hematuria Treatment Market, By Type 2021 & 2028 (%)
9.3 Macroscopic Hematuria
9.3.1 Overview
9.3.2 Macroscopic Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)
9.4 Microscopic Hematuria
9.4.1 Overview
9.4.2 Microscopic Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)
9.5 Idiopathic Hematuria
9.5.1 Overview
9.5.2 Idiopathic Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)
9.6 Jogger’s Hematuria
9.6.1 Overview
9.6.2 Jogger’s Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)
10. Hematuria Treatment Market Revenue and Forecast To 2028 – By End User
10.1 Overview
10.2 Global Hematuria Treatment Market Share by End User 2021 & 2028 (%)
10.3 Hospitals
10.3.1 Overview
10.3.2 Hospitals: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
10.4 Clinics
10.4.1 Overview
10.4.2 Clinics: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
10.5 Ambulatory Surgical Centers (ASC’s)
10.5.1 Overview
10.5.2 Ambulatory Surgical Centers: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
10.6 Others
10.6.1 Overview
10.6.2 Others: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
11. Global Hematuria Treatment Market – Geographic Analysis
11.1 North America: Hematuria Treatment Market
11.1.1 Overview
11.1.2 North America: Hematuria Treatment Market – Revenue and Forecast to 2028 (USD Million)
11.1.3 North America: Hematuria Treatment Market, by Treatment – Revenue and Forecast to 2028 (USD Million)
11.1.4 North America: Hematuria Treatment Market, by Indication – Revenue and Forecast to 2028 (USD Million)
11.1.5 North America: Hematuria Treatment Market, by Type – Revenue and Forecast to 2028 (USD Million)
11.1.6 North America: Hematuria Treatment Market, by End User – Revenue and Forecast to 2028 (USD Million)
11.1.7 North America: Hematuria Treatment Market, by Country, 2021 & 2028 (%)
11.1.7.1 US: Hematuria Treatment Market – Revenue and Forecast to 2028 (USD Million)
11.1.7.1.1 US: Hematuria Treatment Market – Revenue and Forecast to 2028 (USD Million)
11.1.7.1.2 US: Hematuria Treatment Market, by Treatment – Revenue and Forecast to 2028 (USD Million)
11.1.7.1.3 US: Hematuria Treatment Market, by Indication – Revenue and Forecast to 2028 (USD Million)
11.1.7.1.4 US: Hematuria Treatment Market, by Type – Revenue and Forecast to 2028 (USD Million)
11.1.7.1.5 US: Hematuria Treatment Market, by End User – Revenue and Forecast to 2028 (USD Million)
11.1.7.2 Canada: Hematuria Treatment Market – Revenue and Forecast to 2028 (USD Million)
11.1.7.2.1 Canada: Hematuria Treatment Market – Revenue and Forecast to 2028 (USD Million)
11.1.7.2.2 Canada: Hematuria Treatment Market, by Treatment – Revenue and Forecast to 2028 (USD Million)
11.1.7.2.3 Canada: Hematuria Treatment Market, by Indication – Revenue and Forecast to 2028 (USD Million)
11.1.7.2.4 Canada: Hematuria Treatment Market, by Type – Revenue and Forecast to 2028 (USD Million)
11.1.7.2.5 Canada: Hematuria Treatment Market, by End User – Revenue and Forecast to 2028 (USD Million)
11.1.7.3 Mexico: Hematuria Treatment Market – Revenue and Forecast to 2028 (USD Million)
11.1.7.3.1 Mexico: Hematuria Treatment Market – Revenue and Forecast to 2028 (USD Million)
11.1.7.3.2 Mexico: Hematuria Treatment Market, by Treatment – Revenue and Forecast to 2028 (USD Million)
11.1.7.3.3 Mexico: Hematuria Treatment Market, by Indication – Revenue and Forecast to 2028 (USD Million)
11.1.7.3.4 Mexico: Hematuria Treatment Market, by Type – Revenue and Forecast to 2028 (USD Million)
11.1.7.3.5 Mexico: Hematuria Treatment Market, by End User – Revenue and Forecast to 2028 (USD Million)
11.2 Europe: Hematuria Treatment Market
11.2.1 Overview
11.2.2 Europe: Hematuria Treatment Market - Revenue and Forecast to 2028 (US$ Million)
11.2.3 Europe: Hematuria Treatment Market, By Treatment, 2019–2028 (US$ Million)
11.2.4 Europe: Hematuria Treatment Market, By Indication, 2019–2028 (US$ Million)
11.2.5 Europe: Hematuria Treatment Market, by Type, 2019–2028 (US$ Million)
11.2.6 Europe: Hematuria Treatment Market, by End User, 2019–2028 (US$ Million)
11.2.7 Europe: Hematuria Treatment Market, by Country, 2021 & 2028 (%)
11.2.7.1 Germany: Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)
11.2.7.1.1 Germany: Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)
11.2.7.1.2 Germany: Hematuria Treatment Market, By Treatment, 2019–2028 (US$ Million)
11.2.7.1.3 Germany: Hematuria Treatment Market, By Indication, 2019–2028 (US$ Million)
11.2.7.1.4 Germany: Hematuria Treatment Market, by Type, 2019–2028 (US$ Million)
11.2.7.1.5 Germany: Hematuria Treatment Market, by End User, 2019–2028 (US$ Million)
11.2.7.2 France: Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)
11.2.7.2.1 France: Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)
11.2.7.2.2 France: Hematuria Treatment Market, By Treatment, 2019–2028 (US$ Million)
11.2.7.2.3 France: Hematuria Treatment Market, By Indication, 2019–2028 (US$ Million)
11.2.7.2.4 France: Hematuria Treatment Market, by Type, 2019–2028 (US$ Million)
11.2.7.2.5 France: Hematuria Treatment Market, by End user, 2019–2028 (US$ Million)
11.2.7.3 UK: Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)
11.2.7.3.1 UK: Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)
11.2.7.3.2 UK: Hematuria Treatment Market, By Treatment, 2019–2028 (US$ Million)
11.2.7.3.3 UK: Hematuria Treatment Market, By Indication, 2019–2028 (US$ Million)
11.2.7.3.4 UK: Hematuria Treatment Market, by Type, 2019–2028 (US$ Million)
11.2.7.3.5 UK: Hematuria Treatment Market, by End User, 2019–2028 (US$ Million)
11.2.7.4 Italy: Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)
11.2.7.4.1 Italy: Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)
11.2.7.4.2 Italy: Hematuria Treatment Market, By Treatment, 2019–2028 (US$ Million)
11.2.7.4.3 Italy: Hematuria Treatment Market, By Indication, 2019–2028 (US$ Million)
11.2.7.4.4 Italy: Hematuria Treatment Market, by Type, 2019-2028 (US$ Million)
11.2.7.4.5 Italy: Hematuria Treatment Market, by End User, 2019-2028 (US$ Million)
11.2.7.5 Spain: Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)
11.2.7.5.1 Spain: Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)
11.2.7.5.2 Spain: Hematuria Treatment Market, By Treatment, 2019–2028 (US$ Million)
11.2.7.5.3 Spain: Hematuria Treatment Market, By Indication, 2019–2028 (US$ Million)
11.2.7.5.4 Spain: Hematuria Treatment Market, by Type, 2019–2028 (US$ Million)
11.2.7.5.5 Spain: Hematuria Treatment Market, by End User, 2019–2028 (US$ Million)
11.2.7.6 Rest of Europe: Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)
11.2.7.6.1 Rest of Europe: Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)
11.2.7.6.2 Rest of Europe: Hematuria Treatment Market, By Treatment, 2019–2028 (US$ Million)
11.2.7.6.3 Rest of Europe: Hematuria Treatment Market, By Indication, 2019–2028 (US$ Million)
11.2.7.6.4 Rest of Europe: Hematuria Treatment Market, by Type, 2019–2028 (US$ Million)
11.2.7.6.5 Rest of Europe: Hematuria Treatment Market, By End User, 2019–2028 (US$ Million)
11.3 Asia Pacific: Hematuria Treatment Market
11.3.1 Overview
11.3.2 Asia Pacific: Hematuria Treatment Market - Revenue and Forecast to 2028 (US$ Million)
11.3.3 Asia Pacific: Hematuria Treatment Market, by Treatment – Revenue and Forecast to 2028 (US$ Million)
11.3.4 Asia Pacific: Hematuria Treatment Market, by Indication, 2019–2028 (US$ Million)
11.3.5 Asia Pacific: Hematuria Treatment Market, by Type, 2019–2028 (US$ Million)
11.3.6 Asia Pacific: Hematuria Treatment Market, by End User, 2019–2028 (US$ Million)
11.3.7 Asia Pacific: Hematuria Treatment Market, by Country, 2021 & 2028 (%)
11.3.7.1 China: Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)
11.3.7.1.1 China: Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)
11.3.7.1.2 China: Hematuria Treatment Market, by Treatment – Revenue and Forecast to 2028 (US$ Million)
11.3.7.1.3 China: Hematuria Treatment Market, by Indication, 2019–2028 (US$ Million)
11.3.7.1.4 China: Hematuria Treatment Market, by Type, 2019–2028 (US$ Million)
11.3.7.1.5 China: Hematuria Treatment Market, by End User, 2019–2028 (US$ Million)
11.3.7.2 Japan: Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)
11.3.7.2.1 Japan: Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)
11.3.7.2.2 Japan: Hematuria Treatment Market, by Treatment – Revenue and Forecast to 2028 (US$ Million)
11.3.7.2.3 Japan: Hematuria Treatment Market, by Indication, 2019–2028 (US$ Million)
11.3.7.2.4 Japan: Hematuria Treatment Market, by Type, 2019–2028 (US$ Million)
11.3.7.2.5 Japan: Hematuria Treatment Market, by End User, 2019–2028 (US$ Million)
11.3.7.3 India: Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)
11.3.7.3.1 India: Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)
11.3.7.3.2 India: Hematuria Treatment Market, by Treatment – Revenue and Forecast to 2028 (US$ Million)
11.3.7.3.3 India: Hematuria Treatment Market, by Indication, 2019–2028 (US$ Million)
11.3.7.3.4 India: Hematuria Treatment Market, by Type, 2019–2028 (US$ Million)
11.3.7.3.5 India: Hematuria Treatment Market, by End User, 2019–2028 (US$ Million)
11.3.7.4 South Korea: Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)
11.3.7.4.1 South Korea: Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)
11.3.7.4.2 South Korea: Hematuria Treatment Market, by Treatment – Revenue and Forecast to 2028 (US$ Million)
11.3.7.4.3 South Korea: Hematuria Treatment Market, by Indication, 2019–2028 (US$ Million)
11.3.7.4.4 South Korea: Hematuria Treatment Market, by Type, 2019–2028 (US$ Million)
11.3.7.4.5 South Korea: Hematuria Treatment Market, by End User, 2019–2028 (US$ Million)
11.3.7.5 Australia: Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)
11.3.7.5.1 Australia: Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)
11.3.7.5.2 Australia: Hematuria Treatment Market, by Treatment – Revenue and Forecast to 2028 (US$ Million)
11.3.7.5.3 Australia: Hematuria Treatment Market, by Indication, 2019–2028 (US$ Million)
11.3.7.5.4 Australia: Hematuria Treatment Market, by Type, 2019–2028 (US$ Million)
11.3.7.5.5 Australia: Hematuria Treatment Market, by End User, 2019–2028 (US$ Million)
11.3.7.6 Rest of Asia Pacific: Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)
11.3.7.6.1 Rest of Asia Pacific: Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)
11.3.7.6.2 Rest of Asia Pacific: Hematuria Treatment Market, by Treatment – Revenue and Forecast to 2028 (US$ Million)
11.3.7.6.3 Rest of Asia Pacific: Hematuria Treatment Market, by Indication, 2019–2028 (US$ Million)
11.3.7.6.4 Rest of Asia Pacific: Hematuria Treatment Market, by Type, 2019–2028 (US$ Million)
11.3.7.6.5 Rest of Asia Pacific: Hematuria Treatment Market, by End User, 2019–2028 (US$ Million)
11.4 Middle East & Africa: Hematuria Treatment Market
11.4.1 Middle East & Africa: Hematuria Treatment Market– Revenue and Forecast to 2028 (USD Million)
11.4.2 Middle East & Africa: Hematuria Treatment Market, by Treatment- Revenue and Forecast to 2028 (USD Million)
11.4.3 Middle East & Africa: Hematuria Treatment Market, by Indication - Revenue and Forecast to 2028 (USD Million)
11.4.4 Middle East & Africa: Hematuria Treatment Market, by Type- Revenue and Forecast to 2028 (USD Million)
11.4.5 Middle East & Africa: Hematuria Treatment Market, by End User- Revenue and Forecast to 2028 (USD Million)
11.4.6 Middle East & Africa: Hematuria Treatment Market, by Country, 2021& 2028 (%)
11.4.6.1 Saudi Arabia: Hematuria Treatment Market– Revenue and Forecast to 2028 (USD Million)
11.4.6.1.1 Saudi Arabia: Hematuria Treatment Market– Revenue and Forecast to 2028 (USD Million)
11.4.6.1.2 Saudi Arabia: Hematuria Treatment Market, by Treatment- Revenue and Forecast to 2028 (USD Million)
11.4.6.1.3 Saudi Arabia: Hematuria Treatment Market, by Indication- Revenue and Forecast to 2028 (USD Million)
11.4.6.1.4 Saudi Arabia: Hematuria Treatment Market, by Type- Revenue and Forecast to 2028 (USD Million)
11.4.6.1.5 Saudi Arabia: Hematuria Treatment Market, by End User- Revenue and Forecast to 2028 (USD Million)
11.4.6.2 South Africa: Hematuria Treatment Market- Revenue and Forecast to 2028 (USD Million)
11.4.6.2.1 South Africa: Hematuria Treatment Market– Revenue and Forecast to 2028 (USD Million)
11.4.6.2.2 South Africa: Hematuria Treatment Market, by Treatment- Revenue and Forecast to 2028 (USD Million)
11.4.6.2.3 South Africa: Hematuria Treatment Market, by Indication- Revenue and Forecast to 2028 (USD Million)
11.4.6.2.4 South Africa: Hematuria Treatment Market, by Type- Revenue and Forecast to 2028 (USD Million)
11.4.6.2.5 South Africa: Hematuria Treatment Market, by End User- Revenue and Forecast to 2028 (USD Million)
11.4.6.3 UAE: Hematuria Treatment Market– Revenue and Forecast to 2028 (USD Million)
11.4.6.3.1 UAE: Hematuria Treatment Market– Revenue and Forecast to 2028 (USD Million)
11.4.6.3.2 UAE: Hematuria Treatment Market, by Treatment- Revenue and Forecast to 2028 (USD Million)
11.4.6.3.3 UAE: Hematuria Treatment Market, by Indication- Revenue and Forecast to 2028 (USD Million)
11.4.6.3.4 UAE: Hematuria Treatment Market, by Type - Revenue and Forecast to 2028 (USD Million)
11.4.6.3.5 UAE: Hematuria Treatment Market, by End User- Revenue and Forecast to 2028 (USD Million)
11.4.6.4 Rest of Middle East & Africa: Hematuria Treatment Market- Revenue and Forecast to 2028 (USD Million)
11.4.6.4.1 Rest of Middle East & Africa: Hematuria Treatment Market– Revenue and Forecast to 2028 (USD Million)
11.4.6.4.2 Rest of Middle East & Africa: Hematuria Treatment Market, by Treatment- Revenue and Forecast to 2028 (USD Million)
11.4.6.4.3 Rest of Middle East & Africa: Hematuria Treatment Market, by Indication- Revenue and Forecast to 2028 (USD Million)
11.4.6.4.4 Rest of Middle East & Africa: Hematuria Treatment Market, by Type- Revenue and Forecast to 2028 (USD Million)
11.4.6.4.5 Rest of Middle East & Africa: Hematuria Treatment Market, by End User- Revenue and Forecast to 2028 (USD Million)
11.5 South and Central America: Hematuria Treatment Market
11.5.1 Overview
11.5.2 South and Central America: Hematuria Treatment Market - Revenue and Forecast to 2028 (USD Million)
11.5.3 South and Central America Hematuria Treatment Market, By Treatment – Revenue and Forecast to 2028 (USD Million)
11.5.4 South and Central America: Hematuria Treatment Market, by Indication – 2020–2028 (USD Million)
11.5.5 South and Central America Hematuria Treatment Market, By Type – Revenue and Forecast to 2028 (USD Million)
11.5.6 South and Central America Hematuria Treatment Market, By End User – Revenue and Forecast to 2028 (USD Million)
11.5.7 South and Central America: Hematuria Treatment Market Share by Country – 2021 & 2028, (%)
11.5.7.1 Brazil: Hematuria Treatment Market- Revenue and Forecast To 2028 (USD Million)
11.5.7.1.1 Brazil: Hematuria Treatment Market- Revenue and Forecast To 2028 (USD Million)
11.5.7.1.2 Brazil Hematuria Treatment Market, By Treatment – Revenue and Forecast to 2028 (USD Million)
11.5.7.1.3 Brazil: Hematuria Treatment Market, by Indication – 2020–2028 (USD Million)
11.5.7.1.4 Brazil Hematuria Treatment Market, By Type – Revenue and Forecast to 2028 (USD Million)
11.5.7.1.5 Brazil Hematuria Treatment Market, By End User – Revenue and Forecast to 2028 (USD Million)
11.5.7.2 Argentina: Hematuria Treatment Market- Revenue and Forecast To 2028 (USD Million)
11.5.7.2.1 Argentina: Hematuria Treatment Market- Revenue and Forecast To 2028 (USD Million)
11.5.7.2.2 Argentina Hematuria Treatment Market, By Treatment – Revenue and Forecast to 2028 (USD Million)
11.5.7.2.3 Argentina: Hematuria Treatment Market, by Indication – 2020–2028 (USD Million)
11.5.7.2.4 Argentina Hematuria Treatment Market, By Type – Revenue and Forecast to 2028 (USD Million)
11.5.7.2.5 Argentina Hematuria Treatment Market, By End User – Revenue and Forecast to 2028 (USD Million)
11.5.7.3 Rest of South and Central America: Hematuria Treatment Market- Revenue and Forecast To 2028 (USD Million)
11.5.7.3.1 Rest of South and Central America: Hematuria Treatment Market- Revenue and Forecast To 2028 (USD Million)
11.5.7.3.2 Rest of South and Central America Hematuria Treatment Market, By Treatment – Revenue and Forecast to 2028 (USD Million)
11.5.7.3.3 Rest of South and Central America: Hematuria Treatment Market, by Indication – 2020–2028 (USD Million)
11.5.7.3.4 Rest of South and Central America Hematuria Treatment Market, By Type – Revenue and Forecast to 2028 (USD Million)
11.5.7.3.5 Rest of South and Central America Hematuria Treatment Market, By End User – Revenue and Forecast to 2028 (USD Million)
12. Impact Of COVID-19 Pandemic on Hematuria Treatment Market
12.1 North America: Impact Assessment of COVID-19 Pandemic
12.2 Europe: Impact Assessment of COVID-19 Pandemic
12.3 Asia Pacific: Impact Assessment of COVID-19 Pandemic
12.4 Middle East and Africa: Impact Assessment of COVID-19 Pandemic
12.5 South and Central America: Impact Assessment of COVID-19 Pandemic
13. Hematuria Treatment Market–Industry Landscape
13.1 Overview
13.2 Growth Strategies Done by the Companies in the Market, (%)
13.3 Organic Developments
13.3.1 Overview
13.4 Inorganic Developments
13.4.1 Overview
14. Company Profiles
14.1 AstraZeneca
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 Bristol-Myers Squibb Company
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 F. HOFFMANN-LA ROCHE LTD.
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 GlaxoSmithKline Plc
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 Janssen Pharmaceuticals
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 Merck & Co., Inc.
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 Novartis AG
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 Pfizer Inc.
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 Sun Pharmaceutical Industries Ltd
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
14.10 Boehringer Ingelheim International GmbH
14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments
15. Appendix
15.1 About The Insight Partners
15.2 Glossary of Terms
LIST OF TABLES
Table 1. North America: Hematuria Treatment Market, by Treatment – Revenue and Forecast to 2028 (USD Million)
Table 2. North America: Hematuria Treatment Market, by Indication – Revenue and Forecast to 2028 (USD Million)
Table 3. North America: Hematuria Treatment Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 4. North America: Hematuria Treatment Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 5. US: Hematuria Treatment Market, by Treatment – Revenue and Forecast to 2028 (USD Million)
Table 6. US: Hematuria Treatment Market, by Indication – Revenue and Forecast to 2028 (USD Million)
Table 7. US: Hematuria Treatment Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 8. US: Hematuria Treatment Market, by Drug Class – Revenue and Forecast to 2028 (USD Million)
Table 9. Canada: Hematuria Treatment Market, by Treatment – Revenue and Forecast to 2028 (USD Million)
Table 10. Canada: Hematuria Treatment Market, by Indication – Revenue and Forecast to 2028 (USD Million)
Table 11. Canada: Hematuria Treatment Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 12. Canada: Hematuria Treatment Market, by Drug Class – Revenue and Forecast to 2028 (USD Million)
Table 13. Mexico: Hematuria Treatment Market, by Treatment – Revenue and Forecast to 2028 (USD Million)
Table 14. Mexico: Hematuria Treatment Market, by Indication – Revenue and Forecast to 2028 (USD Million)
Table 15. Mexico: Hematuria Treatment Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 16. Mexico: Hematuria Treatment Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 17. Europe: Hematuria Treatment Market, By Treatment – Revenue and Forecast to 2028 (US$ Million)
Table 18. Europe: Hematuria Treatment Market, By Indication– Revenue and Forecast to 2028 (US$ Million)
Table 19. Europe Hematuria Treatment Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 20. Europe Hematuria Treatment Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 21. Germany: Hematuria Treatment Market, By Treatment – Revenue and Forecast to 2028 (US$ Million)
Table 22. Germany: Hematuria Treatment Market, By Indication – Revenue and Forecast to 2028 (US$ Million)
Table 23. Germany: Hematuria Treatment Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 24. Germany: Hematuria Treatment Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 25. France: Hematuria Treatment Market, By Treatment – Revenue and Forecast to 2028 (US$ Million)
Table 26. France: Hematuria Treatment Market, By Indication – Revenue and Forecast to 2028 (US$ Million)
Table 27. France: Hematuria Treatment Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 28. France: Hematuria Treatment Market, by End user – Revenue and Forecast to 2028 (US$ Million)
Table 29. UK: Hematuria Treatment Market, By Treatment – Revenue and Forecast to 2028 (US$ Million)
Table 30. UK: Hematuria Treatment Market, By Indication – Revenue and Forecast to 2028 (US$ Million)
Table 31. UK: Hematuria Treatment Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 32. UK: Hematuria Treatment Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 33. Italy: Hematuria Treatment Market, By Treatment – Revenue and Forecast to 2028 (US$ Million)
Table 34. Italy: Hematuria Treatment Market, By Indication – Revenue and Forecast to 2028 (US$ Million)
Table 35. Italy: Hematuria Treatment Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 36. Italy: Hematuria Treatment Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 37. Spain: Hematuria Treatment Market, By Treatment – Revenue and Forecast to 2028 (US$ Million)
Table 38. Spain: Hematuria Treatment Market, By Indication – Revenue and Forecast to 2028 (US$ Million)
Table 39. Spain: Hematuria Treatment Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 40. Spain: Hematuria Treatment Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 41. Rest of Europe: Hematuria Treatment Market, By Treatment – Revenue and Forecast to 2028 (US$ Million)
Table 42. Rest of Europe: Hematuria Treatment Market, By Indication– Revenue and Forecast to 2028 (US$ Million)
Table 43. Rest of Europe: Hematuria Treatment Market, by Type– Revenue and Forecast to 2028 (US$ Million)
Table 44. Rest of Europe: Hematuria Treatment Market, By End User – Revenue and Forecast to 2028 (US$ Million)
Table 45. Asia Pacific: Hematuria Treatment Market, by Treatment – Revenue and Forecast to 2028 (US$ Million)
Table 46. Asia Pacific: Hematuria Treatment Market, by Indication– Revenue and Forecast to 2028 (US$ Million)
Table 47. Asia Pacific: Hematuria Treatment Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 48. Asia Pacific: Hematuria Treatment Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 49. China: Hematuria Treatment Market, by Treatment – Revenue and Forecast to 2028 (US$ Million)
Table 50. China: Hematuria Treatment Market, by Indication– Revenue and Forecast to 2028 (US$ Million)
Table 51. China: Hematuria Treatment Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 52. China: Hematuria Treatment Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 53. Japan: Hematuria Treatment Market, by Treatment – Revenue and Forecast to 2028 (US$ Million)
Table 54. Japan: Hematuria Treatment Market, by Indication– Revenue and Forecast to 2028 (US$ Million)
Table 55. Japan: Hematuria Treatment Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 56. Japan: Hematuria Treatment Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 57. India: Hematuria Treatment Market, by Treatment – Revenue and Forecast to 2028 (US$ Million)
Table 58. India: Hematuria Treatment Market, by Indication– Revenue and Forecast to 2028 (US$ Million)
Table 59. India: Hematuria Treatment Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 60. India: Hematuria Treatment Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 61. South Korea: Hematuria Treatment Market, by Treatment – Revenue and Forecast to 2028 (US$ Million)
Table 62. South Korea: Hematuria Treatment Market, by Indication– Revenue and Forecast to 2028 (US$ Million)
Table 63. South Korea: Hematuria Treatment Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 64. South Korea: Hematuria Treatment Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 65. Australia: Hematuria Treatment Market, by Treatment – Revenue and Forecast to 2028 (US$ Million)
Table 66. Australia: Hematuria Treatment Market, by Indication– Revenue and Forecast to 2028 (US$ Million)
Table 67. Australia: Hematuria Treatment Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 68. Australia: Hematuria Treatment Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 69. Rest of Asia Pacific: Hematuria Treatment Market, by Treatment – Revenue and Forecast to 2028 (US$ Million)
Table 70. Rest of Asia Pacific: Hematuria Treatment Market, by Indication– Revenue and Forecast to 2028 (US$ Million)
Table 71. Rest of Asia Pacific: Hematuria Treatment Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 72. Rest of Asia Pacific: Hematuria Treatment Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 73. Middle East & Africa Hematuria Treatment Market, by Treatment – Revenue and Forecast to 2028 (USD Million)
Table 74. Middle East & Africa Hematuria Treatment Market, by Indication – Revenue and Forecast to 2028 (USD Million)
Table 75. Middle East & Africa Hematuria Treatment Market, by Type– Revenue and Forecast to 2028 (USD Million)
Table 76. Middle East & Africa Hematuria Treatment Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 77. Saudi Arabia Hematuria Treatment Market, by Treatment – Revenue and Forecast to 2028 (USD Million)
Table 78. Saudi Arabia Hematuria Treatment Market, by Indication – Revenue and Forecast to 2028 (USD Million)
Table 79. Saudi Arabia Hematuria Treatment Market, by Type– Revenue and Forecast to 2028 (USD Million)
Table 80. Saudi Arabia Hematuria Treatment Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 81. South Africa Hematuria Treatment Market, by Treatment – Revenue and Forecast to 2028 (USD Million)
Table 82. South Africa Hematuria Treatment Market, by Indication – Revenue and Forecast to 2028 (USD Million)
Table 83. South Africa Hematuria Treatment Market, by Type– Revenue and Forecast to 2028 (USD Million)
Table 84. South Africa Hematuria Treatment Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 85. UAE Hematuria Treatment Market, by Treatment – Revenue and Forecast to 2028 (USD Million)
Table 86. UAE Hematuria Treatment Market, by Indication – Revenue and Forecast to 2028 (USD Million)
Table 87. UAE Hematuria Treatment Market, by Type– Revenue and Forecast to 2028 (USD Million)
Table 88. UAE Hematuria Treatment Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 89. Rest of Middle East & Africa Hematuria Treatment Market, by Treatment – Revenue and Forecast to 2028 (USD Million)
Table 90. Rest of Middle East & Africa Hematuria Treatment Market, by Indication – Revenue and Forecast to 2028 (USD Million)
Table 91. Rest of Middle East & Africa Hematuria Treatment Market, by Type– Revenue and Forecast to 2028 (USD Million)
Table 92. Rest of Middle East & Africa Hematuria Treatment Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 93. South and Central America Hematuria Treatment Market, By Treatment – Revenue and Forecast to 2028 (USD Million)
Table 94. South and Central America Hematuria Treatment Market, by Indication – Revenue and Forecast to 2028 (USD Million)
Table 95. South and Central America Hematuria Treatment Market, By Type – Revenue and Forecast to 2028 (USD Million
Table 96. South and Central America Hematuria Treatment Market, By End User – Revenue and Forecast to 2028 (USD Thousand)
Table 97. Brazil Hematuria Treatment Market, By Treatment – Revenue and Forecast to 2028 (USD Million)
Table 98. Brazil Hematuria Treatment Market, by Indication – Revenue and Forecast to 2028 (USD Million)
Table 99. Brazil Hematuria Treatment Market, By Type – Revenue and Forecast to 2028 (USD Million)
Table 100. Brazil Hematuria Treatment Market, By End User – Revenue and Forecast to 2028 (USD Million)
Table 101. Argentina Hematuria Treatment Market, By Treatment – Revenue and Forecast to 2028 (USD Million)
Table 102. Argentina Hematuria Treatment Market, by Indication – Revenue and Forecast to 2028 (USD Million)
Table 103. Argentina Hematuria Treatment Market, By Type – Revenue and Forecast to 2028 (USD Million)
Table 104. Argentina Hematuria Treatment Market, By End User – Revenue and Forecast to 2028 (USD Million)
Table 105. Rest of South and Central America Hematuria Treatment Market, By Treatment – Revenue and Forecast to 2028 (USD Million)
Table 106. Rest of South and Central America Hematuria Treatment Market, by Indication – Revenue and Forecast to 2028 (USD Million)
Table 107. Rest of South and Central America Hematuria Treatment Market, By Type – Revenue and Forecast to 2028 (USD Million)
Table 108. Rest of South and Central America Hematuria Treatment Market, By End User – Revenue and Forecast to 2028 (USD Million)
Table 109. Organic Developments Done by Companies
Table 110. Inorganic Developments Done by Companies
Table 111. Glossary of Terms, Hematuria Treatment Market
LIST OF FIGURES
Figure 1. Hematuria Treatment Market Segmentation
Figure 2. Hematuria Treatment Market Segmentation, By Region
Figure 3. Global Hematuria Treatment Market Overview
Figure 4. Macroscopic Hematuria Segment Held the Largest Share of the Type Segment in Hematuria Treatment Market
Figure 5. Asia Pacific to Show Significant Growth During Forecast Period
Figure 6. Hematuria Treatment Market, by Geography (US$ Million)
Figure 7. Global Hematuria Treatment Market – Leading Country Markets (US$ Million)
Figure 8. Global Hematuria Treatment Market, Industry Landscape
Figure 9. North America PEST Analysis
Figure 10. Europe and PEST Analysis
Figure 11. Asia Pacific PEST Analysis
Figure 12. Middle East and Africa PEST Analysis
Figure 13. South and Central America (SCAM) PEST Analysis
Figure 14. Hematuria Treatment Market Impact Analysis of Drivers and Restraints
Figure 15. Global Hematuria Treatment Market – Revenue Forecast and Analysis – 2020- 2028
Figure 16. Global Hematuria Treatment Market – By Geography Forecast and Analysis – 2021 & 2028
Figure 17. Market Positioning of Key Players in Global Hematuria Treatment Market
Figure 18. Global Hematuria Treatment Market Share by Treatment 2021 & 2028 (%)
Figure 19. Drugs: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 20. Therapies: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 21. Others: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 22. Global Hematuria Treatment Market Share by Indication 2021 & 2028 (%)
Figure 23. Kidney Stones: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 24. Urinary Tract Infections: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 25. Urethritis: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 26. Blood Cancer: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 27. Bladder Stones: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 28. Prostate Cancer: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 29. Cystitis: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 30. Trauma: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 31. Vigorous Exercise: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 32. Polycystic Kidney Disease: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 33. Endometriosis: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 34. Menstruation: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 35. Global Hematuria Treatment Market, by Type 2021 & 2028 (%)
Figure 36. Macroscopic Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)
Figure 37. Microscopic Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)
Figure 38. Idiopathic Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)
Figure 39. Jogger’s Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)
Figure 40. Global Hematuria Treatment Market Share by End User 2021 & 2028 (%)
Figure 41. Hospitals: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 42. Clinics: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 43. Academic Institutes: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 44. Others: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 45. North America: Hematuria Treatment Market, by Key Country – Revenue (2021) (USD Million)
Figure 46. North America: Hematuria Treatment Market Revenue and Forecast to 2028 (USD Million)
Figure 47. North America: Hematuria Treatment Market, by Country, 2021 & 2028 (%)
Figure 48. US: Hematuria Treatment Market – Revenue and Forecast to 2028 (USD Million)
Figure 49. Canada: Hematuria Treatment Market – Revenue and Forecast to 2028 (USD Million)
Figure 50. Mexico: Hematuria Treatment Market – Revenue and Forecast to 2028 (USD Million)
Figure 51. Europe: Hematuria Treatment Market, by Key Country – Revenue (2021) (US$ Million)
Figure 52. Europe Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Million)
Figure 53. Europe: Hematuria Treatment Market, by Country, 2021 & 2028 (%)
Figure 54. Germany: Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)
Figure 55. France: Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)
Figure 56. UK: Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)
Figure 57. Italy: Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)
Figure 58. Spain: Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)
Figure 59. Rest of Europe: Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)
Figure 60. Asia Pacific: Hematuria Treatment Market, by Key Country – Revenue (2021) (US$ Million)
Figure 61. Asia Pacific: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Million)
Figure 62. Asia Pacific: Hematuria Treatment Market, by Country, 2021 & 2028 (%)
Figure 63. China: Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)
Figure 64. Japan: Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)
Figure 65. India: Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)
Figure 66. South Korea: Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)
Figure 67. Australia: Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)
Figure 68. Rest of Asia Pacific: Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)
Figure 69. Middle East & Africa: Hematuria Treatment Market, by Key Country – Revenue (2021) (USD Million)
Figure 70. Middle East & Africa Hematuria Treatment Market Revenue and Forecast to 2028 (USD Million)
Figure 71. Middle East & Africa: Hematuria Treatment Market, by Country, 2021& 2028 (%)
Figure 72. Saudi Arabia: Hematuria Treatment Market– Revenue and Forecast to 2028 (USD Million)
Figure 73. South Africa: Hematuria Treatment Market– Revenue and Forecast to 2028 (USD Million)
Figure 74. UAE: Hematuria Treatment Market– Revenue and Forecast to 2028 (USD Million)
Figure 75. Rest of Middle East & Africa: Hematuria Treatment Market– Revenue and Forecast to 2028 (USD Million)
Figure 76. South and Central America: Hematuria Treatment Market, By Key Country – Revenue (2021) (USD Million)
Figure 77. South and Central America: Hematuria Treatment Market- Revenue and Forecast To 2028 (USD Million)
Figure 78. South and Central America: Hematuria Treatment Market Share by Country – 2021 & 2028, (%)
Figure 79. Brazil: Hematuria Treatment Market- Revenue and Forecast To 2028 (USD Million)
Figure 80. Argentina: Hematuria Treatment Market- Revenue and Forecast To 2028 (USD Million)
Figure 81. Rest of South and Central America: Hematuria Treatment Market- Revenue and Forecast To 2028 (USD Million)
Figure 82. Impact Of COVID-19 Pandemic in North America Country Markets
Figure 83. Impact of COVID-19 Pandemic in European Country Markets
Figure 84. Impact of COVID-19 Pandemic in Asia Pacific Countries
Figure 85. Impact Of COVID-19 Pandemic in Middle East and Africa Country Markets
Figure 86. Impact Of COVID-19 Pandemic in South and Central America Country Markets
Figure 87. Growth Strategies Done by the Companies in the Market, (%)
The List of Companies - Hematuria Treatment Market
- AstraZeneca
- Bristol-Myers Squibb Company
- F. HOFFMANN-LA ROCHE LTD.
- GlaxoSmithKline plc.
- Janssen Pharmaceuticals
- Merck & Co., Inc.
- Novartis AG
- Pfizer Inc.
- Sun Pharmaceutical Industries Ltd
- Boehringer Ingelheim International GmbH
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Hematuria Treatment Market
Oct 2021
Aquatic Veterinary Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Diagnostics and Treatments), Species (Fish, Crustaceans, Mollusca, and Others), Disease Source (Bacteria, Viruses, Parasites, and Others), Route of Administration (Water Medication, Medicated Feed, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Oct 2021
Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis By Treatment (Generic Drugs and Originators), Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Oct 2021
Malaria and Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Treatment [Malaria and Sickle Cell Disease (SCD)], Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Oct 2021
Pharmaceutical Contract Sales Organizations Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Services (Commercial Services and Non-Commercial Services), Modules (Syndicated Modules and Dedicated Modules), Therapeutic Area (Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases, Infectious Diseases, and Others), End User (Biopharmaceutical Companies and Pharmaceutical Companies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Oct 2021
Breast Cancer Therapeutics Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Drug Therapy [Targeted Drug Therapy (Abemaciclib, Ado-Trastuzumab Emtansine, Palbociclib, Trastuzumab, and Other Target Drug Therapies), Hormonal Drug Therapy (Selective Estrogen Receptor Modulators, Aromatase Inhibitors, and Selective Estrogen Receptor Downregulators), Chemotherapy, and Immunotherapy/Biological Therapy], Breast Cancer Type (Hormone Receptor, HER2+, and Triple-Negative Breast Cancer), Distribution Channel (Hospital Pharmacies, Drug Stores and Retail Pharmacies, and Online Pharmacies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Oct 2021
Radioactive Tracer Market
Size and Forecast to 2030 - Global Analysis by Tracer Type [Technetium-99m & Tc-97m, Iodine-131, Iron-59, Lutetium-171, Rubidium (Rb-82) Chloride & Ammonia (N-13), Scandium-46, Seaborgium-269, Hassium-269, Gallium Citrate Ga 67, Prostate-Specific Membrane Antigen (PSMA) (Ga-68), FDDNP (F-18) & FDOPA (F-18), Phosphorus-32 & Chromium-51, Thallium-201, F-18 FDG, F-18 FAPI, Ga-68 FAPI, F-18 PSMA, DOTATOC/DOTANOC/DOTATATE (Ga-68), and Others], Test Type (PET, SPECT, and Others), Application (Oncology, Pulmonary, Neurology, Cardiology, and Others) End User (Hospitals & Clinics, Diagnostic Centers, Academic & Research Institutes, And Others), and Geography
Oct 2021
Glioma Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Disease (Astrocytoma, Oligoastrocytoma, and Oligodendroglioma), Treatment Type (Surgery, Chemotherapy, Radiation Therapy, and Others), Grade (Low Grade and High Grade), End User (Hospital & Clinics and Ambulatory Surgical Center), and Geography
Oct 2021
Hyperpigmentation Disorder Treatment Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Treatment Type (Cosmeceutical, Light or Laser Therapy, Microdermabrasion, Chemical Peels, Cryotherapy, and Others), Condition (Melasma, Solar Lentigines, Post-Inflammatory Hyperpigmentation, and Others), End User (Hospitals, Dermatology Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)